Author

A. W. Baird

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Organism:mouse· 1 Organism:rat· 1

Frequent Co-Authors

N. F. Fletcher· 2 shared C. S. McKimmie· 1 shared C. Shannon-Lowe· 1 shared D. A. Lefteri· 1 shared D. Bailey· 1 shared D. Folan· 1 shared D. Goncalves-Carneiro· 1 shared D. Scholz· 1 shared

Activity by Year

2020-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPharmacology & Toxicology

N. F. Fletcher

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Pharmacology & ToxicologybioRxivPreprintOct 5, 2022

A novel antiviral formulation inhibits SARS-CoV-2 infection of human bronchial epithelium

K. Purves, R. Haverty, T. O'Neill…·N. F. Fletcher

This study demonstrates that ViruSAL inhibits SARS-CoV-2 infection in human bronchial epithelial cells and rat models without causing toxicity.

DOI 10.1101/2022.10.05.510928

𝕏 PostBluesky

MicrobiologybioRxivMar 29, 2020

A novel antiviral formulation inhibits a range of enveloped viruses.

N. F. Fletcher, L. W. Meredith, E. L. Tidswell…·A. W. Baird

This study evaluates a novel antiviral formulation, ViroSAL, which inhibits multiple enveloped viruses in vitro and in vivo by disrupting viral envelopes.

DOI 10.1099/jgv.0.001472

mouseexperimental assay

𝕏 PostBluesky